Human papillomavirus vaccines in obstetrics and pediatrics: A comprehensive review

dc.authorid0000-0003-3555-3767
dc.authorid0000-0002-9494-0751
dc.contributor.authorGürbüz, Tuğba
dc.contributor.authorÖzdil Yılmaz, İlkiz Özge
dc.date.accessioned2025-07-30T13:00:38Z
dc.date.available2025-07-30T13:00:38Z
dc.date.issued2025
dc.departmentFakülteler, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, Çocuk Sağlığı ve Hastalıkları Ana Bilim Dalı
dc.description.abstractThis review highlights the epidemiological significance, immunological function, and economic feasibility of Human papillomavirus (HPV) immunization, emphasizing both its benefits and challenges. Addressing vaccine hesitancy, ensuring equitable access, and expanding vaccination coverage for both genders are crucial to maximizing public health benefits. HPV is a highly prevalent infection with significant implications for global public health, particularly in obstetric and pediatric populations. Persistent infection with high-risk HPV genotypes, such as HPV-16 and HPV-18, is a leading cause of cervical cancer, a major contributor to cancer-related mortality worldwide. Beyond cervical malignancies, HPV is etiologically linked to anal, vulvar, vaginal, penile, and oropharyngeal carcinomas. Additionally, it is responsible for benign but distressing conditions such as genital warts, imposing substantial psychosocial and economic burdens. Prophylactic HPV vaccines have significantly improved the prevention of HPV-associated diseases. The currently available bivalent, quadrivalent, and nonavalent vaccines target high-risk oncogenic HPV types and provide near-complete protection against vaccine-included genotypes. These vaccines function by eliciting a robust immune response, effectively neutralizing HPV before it establishes an infection. However, despite their well-documented benefits, challenges such as vaccine hesitancy, misinformation, economic barriers, and global disparities in vaccine access persist. This review provides a comprehensive analysis of HPV immunization within obstetrics and pediatrics, emphasizing its epidemiological impact, immunological mechanisms, efficacy, safety, and implementation strategies. Furthermore, we explore existing barriers to vaccine uptake, disparities in global access, and potential future advancements, including next-generation vaccines and therapeutic interventions. Addressing these challenges through targeted public health initiatives, healthcare provider education, and equitable vaccine distribution strategies is essential to maximizing the public health impact of HPV immunization and reducing the global burden of diseases associated with HPV
dc.identifier.citationGürbüz, T., & Özdil Yılmaz, İ. Ö. (2025). Human papillomavirus vaccines in obstetrics and pediatrics: A comprehensive review. Journal of Controversies in Obstetrics & Gynecology and Pediatrics, 3(3), pp. 68-73. https://doi.org/10.51271/JCOGP-0052
dc.identifier.doi10.51271/JCOGP-0052
dc.identifier.endpage73
dc.identifier.issn2980-0579
dc.identifier.issue3
dc.identifier.startpage68
dc.identifier.urihttps://doi.org/10.51271/JCOGP-0052
dc.identifier.urihttps://hdl.handle.net/20.500.13055/1051
dc.identifier.volume3
dc.institutionauthorÖzdil Yılmaz, İlkiz Özge
dc.institutionauthorid0000-0002-9494-0751
dc.language.isoen
dc.publisherMedihealth Academy
dc.relation.ispartofJournal of Controversies in Obstetrics & Gynecology and Pediatrics
dc.relation.publicationcategoryDiğer
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectHuman Papillomavirus
dc.subjectHPV
dc.subjectHPV Vaccines
dc.subjectCervical Cancer Prevention
dc.subjectVaccine Efficacy and Safety
dc.subjectGlobal Vaccine Acces
dc.titleHuman papillomavirus vaccines in obstetrics and pediatrics: A comprehensive review
dc.typeReview Article
dspace.entity.typePublication

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Tam Metin / Full Text
Boyut:
754.71 KB
Biçim:
Adobe Portable Document Format
Lisans paketi
Listeleniyor 1 - 1 / 1
Kapalı Erişim
İsim:
license.txt
Boyut:
1.17 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: